Rubenbauer Alois Ryan III 13D and 13G filings for Aspire Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-02 08:38 am Purchase | 2026-06-25 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | Rubenbauer Alois Ryan III | 65,000 5.000% | 65,000 (New Position) | Filing |